Skip to content

Home
Stock Stories
US Equities
Ticker Update
Equity Analysis

Menu

Home
Stock Stories
US Equities
Ticker Update
Equity Analysis

Marker Therapeutics Inc.

Industry

Market Analysts see Marker Therapeutics Inc. [MRKR] gaining to $6. Time to buy?

Caleb Clifford April 23, 2021

Finance

Marker Therapeutics Inc. [MRKR] Revenue clocked in at $0.50 million, up 42.07% YTD: What’s Next?

Misty Lee April 8, 2021

Industry

Marker Therapeutics Inc. [MRKR] moved up 18.18: Why It’s Important

Caleb Clifford March 23, 2021

Finance

Piper Sandler slashes price target on Marker Therapeutics Inc. [MRKR] – find out why.

Brandon Evans March 16, 2021

Finance

Market Analysts see Marker Therapeutics Inc. [MRKR] falling to $2.50. Time to buy?

Edison Baldwin February 9, 2021

Industry

Marker Therapeutics Inc. [MRKR] stock Downgrade by Piper Sandler analyst, price target now $2.50

Edison Baldwin December 17, 2020

Company

HomePage
About US
Our Team
Contact US
STOCK STORIES

Categories

Companies
Equity Analysis
Finance
Market
Stock Stories

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Email

© DBT NEWS. All rights reserved.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

About Us
Contact Us
Homepage
Our Team
Thank You